Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2477 |  ARDX Ardelyx, Inc. - Common Stock | 3.80 USD | -2.31% | -5.71% | -25.93% | -38.11% | 946.91 M USD | ||
| 2490 |  ANNX Annexon, Inc. - common stock | 4.84 USD | -4.54% | -4.91% | -8.68% | +110.43% | 917.56 M USD | ||
| 2508 |  DSGN Design Therapeutics, Inc. - Common Stock | 15.01 USD | +0.13% | +1.90% | +16.72% | +186.45% | 939.35 M USD | ||
| 2510 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.40 USD | -2.71% | -2.26% | -13.19% | +26.98% | 909.98 M USD | ||
| 2531 |  IVA Inventiva S.A. - American Depository Shares | 4.64 USD | -0.85% | -0.43% | +4.50% | -2.73% | 896.62 M USD | ||
| 2547 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.01 USD | 0.00% | +0.29% | +0.83% | +18.54% | 883.14 M USD | ||
| 2558 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.64 USD | -7.52% | +9.25% | +43.25% | +29.56% | 808.78 M USD | ||
| 2577 |  DBVT DBV Technologies S.A. - American Depositary Shares | 14.01 USD | -3.71% | -4.04% | +1.89% | +42.81% | 829.56 M USD | ||
| 2579 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 45.05 USD | -1.83% | +5.38% | +20.78% | +49.52% | 841.53 M USD | ||
| 2602 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.51 USD | -2.21% | -3.92% | -11.12% | -19.28% | 807.63 M USD | ||
| 2606 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.72 USD | -3.38% | +4.61% | +24.92% | +144.30% | 794.41 M USD | ||
| 2621 |  AURA Aura Biosciences, Inc. - Common Stock | 7.61 USD | -2.44% | -1.04% | +7.18% | +16.36% | 789.19 M USD | ||
| 2652 |  NGNE Neurogene Inc. - Common Stock | 38.09 USD | -1.40% | +5.10% | +8.83% | +29.47% | 762.23 M USD | ||
| 2656 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.86 USD | -0.72% | +3.63% | +14.14% | -16.95% | 764.96 M USD | ||
| 2657 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 23.47 USD | -0.38% | +23.27% | +21.17% | +240.64% | 764.69 M USD | ||
| 2667 |  STTK Shattuck Labs, Inc. - Common Stock | 7.73 USD | +2.66% | +5.03% | +4.88% | +731.18% | 775.81 M USD | ||
| 2680 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.05 USD | -4.20% | +4.22% | +18.08% | +110.20% | 704.75 M USD | ||
| 2685 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.08 USD | 0.00% | +0.44% | +0.89% | +0.22% | 727.98 M USD | ||
| 2688 |  MNPR Monopar Therapeutics Inc. - Common Stock | 106.13 USD | -1.48% | -8.31% | -3.77% | +94.31% | 712.36 M USD | ||
| 2691 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.02 USD | -3.35% | -1.46% | +12.22% | +66.94% | 697.89 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |